microdosing glp 1 for inflammation Why GLP-1 Microdosing? A Closer Look at Reported Benefits Noom Launches GLP-1 Microdosing for

Our study possesses notable strengths but also certain limitations

The most common side effects (nausea, vomiting, and diarrhea) are usually mild and occur in the first few weeks of treatment, reducing over time

The Scientific Evidence Ozempic, known generically as semaglutide, is primarily FDA-approved for the treatment of type 2 diabetes and the reduction of cardiovascular risk in adults with known heart disease

Besides, GLP-1 can also be produced by neurons in CNS (20, 93)

Zhou et al., 2018)

Limitations Our study is limited by the anonymized data available from the electronic health record systems of participating health care organizations, which may have varying coding practices and data completeness, potentially affecting data quality